evernorth glp-1 Cigna's launches Wegovy, Zepbound copayment cap EncircleRX | Evernorth

- , ...

A National Institutes of Health (NIH)-funded study has found that an emerging class of GLP-1 weight loss drugs suppress eating for pleasure, or hedonic feeding, in mice by modulating a reward circuit deep within the brain

If you are pregnant or lactating, taking medication, or have a medical condition, consult your healthcare practitioner before use

GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential

Explore our detailed breakdown of cash-pay vs covered scenarios including actual year 1 costs.

While our current treatments have shown significant therapeutic benefits, there still appear to be some patients who, despite aggressive therapy, good adherence, and inhaler technique, continue to have exacerbations